Search research articles
Contact Us
Filters
Showing results (51-60 of 90) with videos related to
Page
of 9
Sort By:
Therapeutic Advances in Medical Oncology
|
December 20, 2019
An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)
Emanuela Risi, Chiara Biagioni, Matteo Benelli, et al.
Genome Biology
|
November 1, 2013
EXCAVATOR: detecting copy number variants from whole-exome sequencing data
Alberto Magi, Lorenzo Tattini, Ingrid Cifola, et al.
Genome Medicine
|
February 4, 2026
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing
Marta Paoli, Francesca Galardi, Agostina Nardone, et al.
Cells
|
May 13, 2026
Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells
Giulia Lori, Caterina Mancini, Caterina Paffetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2020
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial
Amelia McCartney, Martina Bonechi, Francesca De Luca, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2019
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
Amelia McCartney, Chiara Biagioni, Gaia Schiavon, et al.
Breast Cancer Research : BCR
|
March 25, 2021
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial
Francesca Galardi, Francesca De Luca, Chiara Biagioni, et al.
Scientific Reports
|
August 3, 2021
The incremental value of computed tomography of COVID-19 pneumonia in predicting ICU admission
Maurizio Bartolucci, Matteo Benelli, Margherita Betti, et al.
Journal of Human Genetics
|
October 14, 2016
A novel founder MYO15A frameshift duplication is the major cause of genetic hearing loss in Oman
Flavia Palombo, Nadia Al-Wardy, Guido Alberto Gnecchi Ruscone, et al.
The Journal of Clinical Investigation
|
February 25, 2020
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer
Himisha Beltran, Alessandro Romanel, Vincenza Conteduca, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 90) with videos related to
Sort By:
Page
of 9
Therapeutic Advances in Medical Oncology
|
December 20, 2019
An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06)
Emanuela Risi, Chiara Biagioni, Matteo Benelli, et al.
Genome Biology
|
November 1, 2013
EXCAVATOR: detecting copy number variants from whole-exome sequencing data
Alberto Magi, Lorenzo Tattini, Ingrid Cifola, et al.
Genome Medicine
|
February 4, 2026
A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing
Marta Paoli, Francesca Galardi, Agostina Nardone, et al.
Cells
|
May 13, 2026
Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer Cells
Giulia Lori, Caterina Mancini, Caterina Paffetti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2020
Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial
Amelia McCartney, Martina Bonechi, Francesca De Luca, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 7, 2019
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT)
Amelia McCartney, Chiara Biagioni, Gaia Schiavon, et al.
Breast Cancer Research : BCR
|
March 25, 2021
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial
Francesca Galardi, Francesca De Luca, Chiara Biagioni, et al.
Scientific Reports
|
August 3, 2021
The incremental value of computed tomography of COVID-19 pneumonia in predicting ICU admission
Maurizio Bartolucci, Matteo Benelli, Margherita Betti, et al.
Journal of Human Genetics
|
October 14, 2016
A novel founder MYO15A frameshift duplication is the major cause of genetic hearing loss in Oman
Flavia Palombo, Nadia Al-Wardy, Guido Alberto Gnecchi Ruscone, et al.
The Journal of Clinical Investigation
|
February 25, 2020
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer
Himisha Beltran, Alessandro Romanel, Vincenza Conteduca, et al.
Page
of 9